Kingston Rhode Island based MindImmune Therapeutics is raising $8,880,000.00 in New Equity Investment.
Kingston, RI – According to filings with the U.S. Securities and Exchange Commission, MindImmune Therapeutics is raising $8,880,000.00 in new funding. Sources indicate as part of senior management President, Stevin Zorn played a key role…